P22681 (CBL_HUMAN) Homo sapiens (Human)

E3 ubiquitin-protein ligase CBL UniProtKBInterproStringInteractive Modelling

906 aa; Sequence (Fasta) Identical sequences: Pan troglodytes: H2Q4Y2

Sequence Features

 287K -> R (found in patients with acute myeloid leukemia; unknown pathological significance). VAR_071040
 365Q -> QSK (found in patients with acute myeloid leukemia; unknown pathological significance; loss of the ability to negatively regulate signaling pathways; promotes cell cycle progression; decreases apoptosis). VAR_071041
 367Q -> P (in NSLL; dbSNP:rs267606704). VAR_064332 dbSNP
 371Y -> H (found in patients with acute myeloid leukemia; unknown pathological significance; loss of the ability to negatively regulate signaling pathways; promotes cell cycle progression; decreases apoptosis; dbSNP:rs267606706). VAR_071042 dbSNP
 382K -> E (in NSLL; dominant-negative; impairs CBL-mediated ubiquitination, internalization and degradation of the EGF receptor/EGFR; decreases the ability to negatively regulate EGFR signaling; dbSNP:rs267606705). VAR_064333 dbSNP
 390D -> Y (in NSLL; dominant-negative; impairs CBL-mediated ubiquitination, internalization and degradation of the EGF receptor/EGFR; decreases the ability to negatively regulate EGFR signaling; dbSNP:rs267606707). VAR_064334 dbSNP
 420R -> Q (in NSLL; dominant-negative; impairs CBL-mediated ubiquitination, internalization and degradation of the EGF receptor/EGFR; decreases the ability to negatively regulate EGFR signaling; dbSNP:rs267606708). VAR_064335 dbSNP
 499R -> L (found in patients with acute myeloid leukemia; unknown pathological significance). VAR_071043
 620L -> F (in dbSNP:rs2227988). VAR_057211 dbSNP
 782P -> L (in dbSNP:rs2229073). VAR_057212 dbSNP
 904V -> I (in dbSNP:rs17122769). VAR_057213 dbSNP
 227-240
 381-420RING-type.
 51-175Adaptor protein Cbl, N-terminal helical
IPR003153PF02262
 179-262Adaptor protein Cbl, EF hand-like
IPR014741PF02761
 264-349Adaptor protein Cbl, SH2-like domain
IPR014742PF02762
 858-892Ubiquitin-associated domain
IPR015940PF00627

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownload
Structure of c-Cbl-ZAP-70 peptide complex Heteromer
P43403;
ZN;CA;2y1n47-435
Structure of phosphoTyr371-c-Cbl-UbcH5B-ZAP-70 complex Heteromer
P43403; P62837;
ZN;CA;4a4c47-435
Structure of modified phosphoTyr371-c-Cbl-UbcH5B-ZAP-70 complex Heteromer
P43403; P62837;
ZN;CA;4a4b47-435
STRUCTURE OF A CBL-UBCH7 COMPLEX: RING DOMAIN FUNCTION IN UBIQUITIN-PROTEIN LIGASES Heteromer
P43403; P68036;
ZN;SO4;1fbv47-434
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in c-Met Heteromer
P08581;
3bux23-351
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in Syk Heteromer
P43405;
3buw23-351
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in Sprouty4 Heteromer
Q9C004;
3bun23-351
Crystal Structure of the c-Cbl TKB Domain in Complex with the APS pTyr-618 Phosphopeptide Heteromer
Q9Z200;
MG;1yvh23-351
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in EGF receptor' Heteromer
P00533;
3buo23-351
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in Sprouty2 Heteromer
O43597;
3bum25-351
Crystal structure of c-Cbl TKB domain in complex with double phosphorylated EGFR peptide Heteromer
P00533;
3ob225-351
Crystal structure of c-Cbl TKB domain in complex with double phosphorylated Spry2 peptide Heteromer
O43597;
3ob125-351
'Crystal structure of c-Cbl TKBD domain in complex with SPRY2 peptide (36-60, pY55) Refined to 1.... Heteromer
O43597;
NA;1PE;CL;5hky47-351
'Crystal Structure of c-Cbl TKBD in complex with SPRY2 peptide (36-60, pY55) Refined to 1.8 A Res... Heteromer
O43597;
NA;5hkz47-351
N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE ON ZAP-70 Heteromer
P22681; P43403;
CA;2cbl47-351
'Crystal Structure of c-Cbl TKBD in complex with SPRY2 peptide (54-60, pY55) Refined to 2.2A Reso... Heteromer
O43597;
NA;5hl047-351
Structure of phosphoTyr371-c-Cbl-UbcH5B complex Heteromer
P62837;
ZN;K;4a49354-435
Structure of Cbl(TKB) bound to a phosphorylated pentapeptidehomo-3-mer 4gpl47-351
STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70homo-3-mer CA;1b4747-350
crystal structure of the UBA domain from human c-Cbl ubiquitin ligasehomo-2-mer 2oo9856-895
Crystal Structure of c-Cbl TKBD-RING domains (Y371E mutant) Refined to 1.85 A Resolutionmonomer NA;ZN;EDO;5hkx47-435
Structure of native c-Cblmonomer ZN;CA;2y1m47-435
Structure of c-CBL Y371Fmonomer ZN;CA;5j3x47-435
Reverse Binding Mode of MetRD peptide complexed with c-Cbl TKB domainmonomer CA;CL;3plf25-351
Crystal Structure of Apo c-Cbl TKBD Refined to 2.25 A Resolutionmonomer NA;5hkw47-351
E2-c-Cbl recognition is necessary but not sufficient for ubiquitination activitymonomer ZN;2k4d358-437
Solution Structure of the UBA domain from c-Cblmonomer 2juj851-906